Stock
Stock

Bionano Genomics

3.99

Delay
0
Open
4.08
Market Cap
13.79M+
High
4.29
Low
3.91
Close
3.99
Volume
135.79K+
P/E Ratio
-0.05
Div/Yield
0.00%
Track The Stock Movement

About Bionano Genomics

Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight. The company also provides Saphyr and Bionano compute servers; and NxClinical which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; EpiPanelDx PLUS, a genetic testing panel for patients who have experienced seizures, infantile spasms, encephalopathy, or febrile seizures; PGx test, which identifies over 60 alleles in 11 genes. The company was founded in 2003 and is headquartered in San Diego, California.

Trade GPT

logo

Compañía

Social

Descargar

google playapp store

© 2025 Rockalpha Limited. Todos los Derechos Reservados.

Rockalpha Limited está inscrita en el Registro de Proveedores de Servicios Financieros de Nueva Zelanda (FSP: 1001454). El registro de Proveedores de Servicios Financieros de Rockalpha Limited puede verificarse en el Registro de Proveedores de Servicios Financieros. Rockalpha Limited es miembro del Insurance & Financial Services Ombudsman Scheme, un proveedor independiente de servicios de resolución de disputas. Rockalpha Limited no está autorizada por ningún organismo regulador neozelandés para prestar servicios monetarios o inmobiliarios a clientes, y la inscripción de Rockalpha Limited en el registro neozelandés de proveedores de servicios financieros o su pertenencia al Insurance & Financial Services Ombudsman Scheme no significa que Rockalpha Limited esté sujeta a la regulación o supervisión activa de un organismo regulador neozelandés.Rockalpha Limited está inscrita en el Registro de Proveedores de Servicios Financieros de Nueva Zelanda (FSP: 1001454). El registro de Proveedores de Servicios Financieros de Rockalpha Limited puede verificarse en el Registro de Proveedores de Servicios Financieros. Rockalpha Limited es miembro del Insurance & Financial Services Ombudsman Scheme, un proveedor independiente de servicios de resolución de conflictos.

Rockalpha Limited, operates from its Singapore headquarters at CapitaSky 808, 79 Robinson Road, Singapore 068897, with a regional office at Level 6, Core C, Cyberport 3, 100 Cyberport Road, Hong Kong.